The Existence of Symptomatic Localized Lesion(s) and ≤4 Lesions Are Indications for Radiotherapy: Screening Computed Tomography Images of Patients with Metastatic/Recurrent/Inoperable Cancer in a Single Japanese Institution Observational Study
Background: To investigate the prevalence of indications for radiotherapy (RT) in patients with metastatic/recurrent/inoperable cancer. We also sought to analyze such patients’ clinical and radiological characteristics for indications of radiotherapy in those patients who had either surveillance or an initial assessment done by computed tomography (CT). Methods: Two diagnostic radiologists and a radiation oncologist evaluated a total of 13,225 consecutive patients from January 2012 to December 2012 at a single Japanese institution. Patients with metastatic/recurrent/ inoperable cancer were selected for further study. After two diagnostic radiologists identified patients with a detectable cancerous lesion, a radiation oncologist subsequently investigated whether there was any indication for RT. The oncologist also evaluated the relationship between patients’ clinical/radiological factors, and patients with or without indications for RT. Results: Two diagnostic radiologists selected 329 patients showing a detectable gross cancerous lesion. In this patient group, a radiation oncologist identified 196 patients with metastatic/recurrent/inoperable cancer, of which 96 patients (49%) showed an indication for RT. According to both univariate and multivariate analyses, ≤4 lesions were significantly associated with patients who showed an indication for RT (P = 0.0002 and P < 0.0001, respectively). The existence of symptomatic, localized lesion(s) was also significantly associated with those who showed an indication for RT (P < 0.001 and P > 0.001, respectively). Conclusions: In screening CT images, approximately half of all patients with metastatic/recurrent/inoperable cancer showed an indication for RT. Moreover, ≤4 lesions and/or the existence of a symptomatic, localized lesion were highly suggestive of an indication for RT. These findings would be of considerable interest to radiation oncologists planning appropriate treatments for cancer patients.
References
[1]
Ashby, M. (1991) The Role of Radiotherapy in Palliative Care. Journal of Pain and Symptom Management, 6, 380-388. http://dx.doi.org/10.1016/0885-3924(91)90030-8
[2]
Coia, L.R., Owen, J.B., Maher, E.J. and Hanks, G.E. (1992) Factors Affecting Treatment Patterns of Radiation Oncology in the United States in the Palliative Treatment of Cancer. Clinical Oncology, 4, 6-10. http://dx.doi.org/10.1016/S0936-6555(05)80762-9
[3]
Fine, P. (2002) Palliative Radiation Therapy in End-of-Life Care: Evidence-Based Utilization. American Journal of Hospice & Palliative Care, 19, 166-170. http://dx.doi.org/10.1177/104990910201900307
[4]
Delaney, G., Jacob, S., Featherstone, C. and Barton, M. (2005) The Role of Radiotherapy in Cancer Treatment: Estimating Optimal Utilization from a Review of Evidence-Based Clinical Guidelines. Cancer, 15, 1129-1137. http://dx.doi.org/10.1002/cncr.21324
[5]
Tisdale, B.A. (1999) When to Consider Radiation Therapy for Your Patient. American Family Physician, 59, 1177-1184.
[6]
Levitt, S.H. and Leer, J.W. (1996) The Role of Radiotherapy in Sweden: A Landmark Study by the Swedish Council on Technology Assessment in Health Care. Acta Oncologica, 35, 965-966. http://dx.doi.org/10.3109/02841869609100713
[7]
MacKillop, W.J., Groome, P.A., Zhang-Salomons, J., Zhou, Y., Feldman-Stewart, D., Paszat, L., et al. (1997) Does a Centralized Radiotherapy System Provide Adequate Access to Care? Journal of Clinical Oncology, 15, 1261-1271.
[8]
ISCRO (1991) Radiation Oncology in Integrated Cancer Management: Report of the Inter-Society Council for Radiation Oncology. American College of Radiology, Reston.
[9]
Teshima, T., Numasaki, H., Shibuya, H., Nishio, M., Ikeda, H., Sekiguchi, K., et al. (2010) Japanese Structure Survey of Radiation Oncology in 2007 Based on Institutional Stratification of Patterns of Care Study. International Journal of Radiation Oncology*Biology*Physics, 78, 1483-1493. http://dx.doi.org/10.1016/j.ijrobp.2009.10.019
[10]
Eisenhauer, E.A., Therasse, P., Bogaerts, J., Schwartz, L.H., Sargent, D., Ford, R., et al. (2009) New Response Evaluation Criteria in Solid Tumours: Revised RECIST Guideline (Version 1.1). European Journal of Cancer, 45, 228-247. http://dx.doi.org/10.1016/j.ejca.2008.10.026
[11]
Therasse, P., Arbuck, S.G., Eisenhauer, E.A., Wanders, J., Kaplan, R.S., Rubinstein, L., et al. (2000) New Guidelines to Evaluate the Response to Treatment in Solid Tumors. Journal of the National Cancer Institute, 92, 205-216. http://dx.doi.org/10.1093/jnci/92.3.205
[12]
Samant, R.S., Fitzgibbon, E., Meng, J. and Graham, I.D. (2006) Family Physicians’ Perspectives Regarding Palliative Radiotherapy. Radiotherapy & Oncology, 78, 101-106. http://dx.doi.org/10.1016/j.radonc.2005.11.008
[13]
Vulto, A., van Bommel, M., Poortmans, P., Lybeert, M., Louwman, M., Baart, R., et al. (2009) General Practitioners and Referral for Palliative Radiotherapy: A Population-Based Survey. Radiotherapy & Oncology, 91, 267-270.
[14]
Niibe, Y., Kenjo, M., Kazumoto, T., Michimoto, K., Takayama, M., Yamauchi, C., et al. (2006) Multi-Institutional Study of Radiation Therapy for Isolated Para-Aortic Lymph Node Recurrence in Uterine Cervical Carcinoma: 84 Subjects of a Population of More than 5000. International Journal of Radiation Oncology*Biology*Physics, 66, 1366-1369. http://dx.doi.org/10.1016/j.ijrobp.2006.07.1384
[15]
Hellman, S. and Weichselbaum, R.R. (1995) Oligometastases. Journal of Clinical Oncology, 13, 8-10.
[16]
Niibe, Y., Kuranami, M., Matsunaga, K., Takaya, M., Kakita, S., Hara, T., et al. (2008) Value of High-Dose Radiation Therapy for Isolated Osseous Metastasis in Breast Cancer in Terms of Oligo-Recurrence. Anticancer Research, 28, 3929-3931.
[17]
Niibe, Y. and Hayakawa, K. (2010) Oligometastases and Oligorecurrence: The New Era of Cancer Therapy. Japanese Journal of Clinical Oncology, 40, 107-111. http://dx.doi.org/10.1093/jjco/hyp167
[18]
Inoue, T., Katoh, N., Aoyama, H., Onimaru, R., Taguchi, H., Onodera, S., et al. (2010) Clinical Outcomes of Stereotactic Brain and/or Body Radiotherapy for Patients with Oligometastatic lesions. Japanese Journal of Clinical Oncology, 40, 788-794. http://dx.doi.org/10.1093/jjco/hyq044
[19]
Niibe, Y., Nishimura, T., Inoue, T., Karasawa, K., Shioyama, Y., Ogawa, Y., Takemoto, M. and Shirato, H. (2010) Oligometastases of Brain only in Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Stereotactic Irradiation (STI): A Multi-Institutional Study. International Journal of Radiation Oncology*Biology*Physics, 78, S497. http://dx.doi.org/10.1016/j.ijrobp.2010.07.1163
[20]
Guerra, J.L.L., Gomez, D., Zhuang, Y., Hong, D.S., Heymach, J.V., Swisher, S.G., Lin, S.H., Komaki, R., Cox, J.D. and Liao, Z. (2012) Prognostic Impact of Radiation Therapy to the Primary Tumor in Patients with Non-Small Cell Lung Cancer and Oligometastasis at Diagnosis. International Journal of Radiation Oncology*Biology*Physics, 84, 61-67. http://dx.doi.org/10.1016/j.ijrobp.2012.02.054
[21]
Mackillop, W.J., Groome, P.A., Zhang-Salomons, J., Zhou, Y., Feldman-Stewart, D., et al. (1997) Does a Centralized Radiotherapy System Provide Adequate Access to Care? Journal of Clinical Oncology, 15, 1261-1271.
